The incidence of diabetes following mRNA, inactivated COVID-19 vaccines, and after SARS-CoV-2 infection

FHS
July 31, 2023
11:12 am

Researchers evaluate the risk of new-onset diabetes linked with COVID-19 vaccination and infection.

After Amylyx ALS trial failure, patients share disappointment and fear — but some hope

The news last week that a Phase 3 trial of Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug — marketed as Relyvrio — failed to benefit patients

March 12, 2024

BSIM Healthcare Services to Deploy Innovaccer’s AI Platform

What You Should Know: – Innovaccer Inc., a healthcare artificial intelligence (AI) company, today announced a significant partnership with BSIM Healthcare Services. – BSIM, dedicated

June 21, 2024

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology | Psychedelic Invest

TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) — Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.